189 related articles for article (PubMed ID: 3170992)
41. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis.
Di Bona D; Plaia A; Scafidi V; Leto-Barone MS; Di Lorenzo G
J Allergy Clin Immunol; 2010 Sep; 126(3):558-66. PubMed ID: 20674964
[TBL] [Abstract][Full Text] [Related]
42. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
Williams A; Henzgen M; Rajakulasingam K
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
[TBL] [Abstract][Full Text] [Related]
43. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens.
Balda BR; Wolf H; Baumgarten C; Klimek L; Rasp G; Kunkel G; Müller S; Mann W; Hauswald B; Heppt W; Przybilla B; Amon U; Bischoff R; Becher G; Hummel S; Frosch PJ; Rustemeyer T; Jäger L; Brehler R; Luger T; Schnitker J
Allergy; 1998 Aug; 53(8):740-8. PubMed ID: 9722222
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
Allergy; 2009 Jan; 64(1):179-86. PubMed ID: 19076534
[TBL] [Abstract][Full Text] [Related]
45. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
46. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis.
Grammer LC; Shaughnessy MA; Finkle SM; Shaughnessy JJ; Patterson R
J Allergy Clin Immunol; 1986 Dec; 78(6):1180-4. PubMed ID: 3537093
[TBL] [Abstract][Full Text] [Related]
47. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
48. Long-term efficacy of preseasonal grass pollen immunotherapy in children.
Eng PA; Reinhold M; Gnehm HP
Allergy; 2002 Apr; 57(4):306-12. PubMed ID: 11906360
[TBL] [Abstract][Full Text] [Related]
49. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
[TBL] [Abstract][Full Text] [Related]
50. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.
Wahn U; Klimek L; Ploszczuk A; Adelt T; Sandner B; Trebas-Pietras E; Eberle P; Bufe A;
J Allergy Clin Immunol; 2012 Oct; 130(4):886-93.e5. PubMed ID: 22939758
[TBL] [Abstract][Full Text] [Related]
51. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
[TBL] [Abstract][Full Text] [Related]
52. Polyvalent Mechanical Bacterial Lysate Administration Improves the Clinical Course of Grass Pollen-Induced Allergic Rhinitis in Children: A Randomized Controlled Trial.
Janeczek K; Emeryk A; Rachel M; Duma D; Zimmer Ł; Poleszak E
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):453-462. PubMed ID: 32858239
[TBL] [Abstract][Full Text] [Related]
53. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
54. Long-term clinical efficacy of grass-pollen immunotherapy.
Durham SR; Walker SM; Varga EM; Jacobson MR; O'Brien F; Noble W; Till SJ; Hamid QA; Nouri-Aria KT
N Engl J Med; 1999 Aug; 341(7):468-75. PubMed ID: 10441602
[TBL] [Abstract][Full Text] [Related]
55. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract.
Horst M; Hejjaoui A; Horst V; Michel FB; Bousquet J
J Allergy Clin Immunol; 1990 Feb; 85(2):460-72. PubMed ID: 2406323
[TBL] [Abstract][Full Text] [Related]
56. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy.
Didier A; Melac M; Montagut A; Lhéritier-Barrand M; Tabar A; Worm M
Allergy; 2009 Jan; 64(1):166-71. PubMed ID: 19076546
[TBL] [Abstract][Full Text] [Related]
57. Combination of parenteral and oral immunotherapy in grass pollen-allergic children. A double-blind controlled study of clinical and immunological efficacy.
Trede NS; Urbanek R
Allergy; 1989 May; 44(4):272-80. PubMed ID: 2735516
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of sublingual swallow immunotherapy in children with rye grass pollen allergic rhinitis: a double-blind placebo-controlled study.
Ahmadiafshar A; Maarefvand M; Taymourzade B; Mazloomzadeh S; Torabi Z
Iran J Allergy Asthma Immunol; 2012 Jun; 11(2):175-81. PubMed ID: 22761191
[TBL] [Abstract][Full Text] [Related]
59. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
[TBL] [Abstract][Full Text] [Related]
60. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
Dahl R; Stender A; Rak S
Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
